Log in or Sign up for Free to view tailored content for your specialty!
Gynecologic Cancer News
Levonorgestrel intrauterine device induces response in early endometrial cancer, precancer
Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with stage I endometrial adenocarcinoma or endometrial hyperplasia with atypia, according to results of a randomized, phase 2 study.
Survey: Most female gynecologic oncologists have faced workplace bullying, harassment
Most female gynecologic oncologists who responded to an internet-based survey reported having experienced workplace bullying, according to a presentation at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Log in or Sign up for Free to view tailored content for your specialty!
Time to surgery linked to survival among women with high-grade endometrial cancer
Regionalization of care for high-grade endometrial cancer in Ontario had no negative effect on surgical wait times, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Preterm birth risk higher among women with early cervical cancer
Women with early cervical cancer who conceived at least 3 months after fertility-sparing surgery had a high live birth rate, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Olaparib maintenance confers durable PFS benefit in advanced BRCA-mutated ovarian cancer
Olaparib maintenance significantly extended 5-year PFS for women with advanced BRCA-positive ovarian cancer, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Chemotherapy for gynecologic cancer does not increase COVID-19 hospitalization, death
Chemotherapy did not increase risk for hospitalization or death due to COVID-19 among women with gynecologic cancer, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Minimally invasive surgery may be effective for advanced epithelial ovarian cancer
Minimally invasive interval debulking surgery may benefit women with advanced epithelial ovarian cancer who received neoadjuvant chemotherapy, findings presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed.
Lenvatinib-pembrolizumab combination extends PFS, OS in advanced endometrial cancer
Lenvatinib plus pembrolizumab improved outcomes vs. chemotherapy for women with advanced endometrial cancer, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Perlmutter Cancer Center appoints director of gynecologic oncology
Leslie R. Boyd, MD, has been appointed director of the division of gynecologic oncology at Laura and Isaac Perlmutter Cancer Center at NYU Langone Health.
High cadmium intake linked to shorter OS among women with endometrial cancer
High daily dietary cadmium intake appeared associated with shorter OS among women with endometrial cancer, according to study results published in Nutrition and Cancer.